Loading clinical trials...
Loading clinical trials...
Randomized, Double-blind, Placebo-controlled Clinical Trial of Nicotinamide Mononucleotide on Muscle Recovery and Physical Capacity in Healthy Volunteers With Moderate Physical Activity
Conditions
Interventions
Nicotinamide mononucleotide
Placebo
Locations
1
France
CEN Nutriment
Dijon, France
Start Date
March 9, 2021
Primary Completion Date
November 10, 2022
Completion Date
May 30, 2023
Last Updated
January 17, 2024
NCT07521878
NCT06359210
NCT07477184
NCT07140770
NCT06810180
NCT07438808
Lead Sponsor
Seneque SA
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions